NCT05173740 Rehabilitation for Survivors of Out-of-hospital Cardiac Arrest
| NCT ID | NCT05173740 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Rigshospitalet, Denmark |
| Condition | Cardiac Arrest |
| Study Type | INTERVENTIONAL |
| Enrollment | 214 participants |
| Start Date | 2022-02-01 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 214 participants in total. It began in 2022-02-01 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a parallel group multicentre investigator-initiated clinical randomised controlled superiority trial that will include a total of 214 survivors of OHCA. Participants will to be randomized with a 1:1 allocation ratio to either a intervention consisting of a comprehensive initiated tailored rehabilitation intervention focusing on supporting RTW plus usual care compared to usual care alone.
Eligibility Criteria
Inclusion criteria: * All adult survivors with first time out-of-hospital cardiac arrest * Discharged from the Hospitals will be assessed eligible for inclusion Exclusion criteria: * Survivors who prior to the cardiac arrest were not part of the labour force with at least two years until they are qualified to receive retirement state pensions * Patients that cannot understand and fulfil the study surveys (in Danish) * Patients with short witnessed cardiac arrests with return of spontaneous circulation estimated less than 4 minutes and immediate awakening without ICU treatment
Contact & Investigator
Jan Christensen, PhD
PRINCIPAL INVESTIGATOR
Department of Occupational Therapy and Physiotherapy, Rigshospitalet, Denmark
Frequently Asked Questions
Who can join the NCT05173740 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Cardiac Arrest. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT05173740 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT05173740 currently recruiting?
Yes, NCT05173740 is actively recruiting participants. Contact the research team at fysjan@gmail.com for enrollment information.
Where is the NCT05173740 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT05173740 clinical trial?
NCT05173740 is sponsored by Rigshospitalet, Denmark. The principal investigator is Jan Christensen, PhD at Department of Occupational Therapy and Physiotherapy, Rigshospitalet, Denmark. The trial plans to enroll 214 participants.